Asia Pacific Metabolomics Services Market

Market Introduction

Asia Pacific (APAC) is the fastest-growing regional market for metabolomics services; and China, India, Japan, South Korea, Australia, and Rest of APAC are the major contributors to the market in this region. Asia Pacific is likely to account for over 25.68% market share of the global metabolomics services market in 2021 owing to the growing investments from international players in China and India, improving government support in countries, expanding base of CRO services, and advancing healthcare infrastructure. Therefore, the region holds huge potential for the metabolomics services market players to grow during the forecast period. The Japanese healthcare industry is witnessing massive developments and financial aids to accelerate its adoption and acceptance of cell therapy-based products. The government focuses on developing laws and policies to bolster the innovations and discoveries in novel diagnostics and therapeutics such as regenerative medicine. The country has the presence of contract research organizations which in turn is expected to support the market growth. The players in the related markets are actively investing in Japan. Development opportunities in several countries is the major factor driving the growth of the APAC metabolomics services market.

As a result of the ongoing COVID-19 pandemic, the healthcare sector is under tremendous pressure. The containment and social distancing measures have led to disruption in supply chains. Moreover, the demand for efficient diagnostics and treatments of COVID-19 has gained huge paramount importance in Asia Pacific. India, China, Japan, and South Korea are among the countries in the region that are experiencing various adverse effects due to the pandemic, which include damaged socioeconomics, inflation, low GDPs, and unemployment surge. Countries such as China, Japan, Singapore, and South Korea engaged in rapid clinical trials. High costs of operations in western countries drive the flow of medical affairs outsourcing to Asia Pacific. To leverage these opportunities, pharmaceutical companies in this region gaining expertise on new and changing regulatory environments for drugs, devices, and in-vitro diagnostics. New or improved regulations are implemented frequently in Asia, including changes in GMP standards, drug price controls, and medical device regulatory systems. Third-party guidance and advice are required for any new standard acquisition or improvements. Increasingly, third-party outsourcing service providers are playing a more significant role in supporting the associated markets in Asia Pacific. As of 2021, the market has stabilized owing to control procedures, awareness among people, vaccine development and administration, and supportive government policies boosting business growth.

Asia Pacific Metabolomics Services Strategic Insights

Strategic insights for the Asia Pacific Metabolomics Services provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Metabolomics Services Report Scope

Asia Pacific Metabolomics Services Regional Insights

The geographic scope of the Asia Pacific Metabolomics Services refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The metabolomics services market in APAC is expected to grow from US$ 110.42 million in 2021 to US$ 438.91 million by 2028; it is estimated to grow at a CAGR of 21.8% from 2021 to 2028. Metabolomics is among the growing and robust technologies for detecting a wide range of metabolites in tissues and biofluids. This process has a significant application in the analysis and studies associated with cancer disease. The rising prevalence of different types of cancer is expected to drive the market during the forecast period. Cancer diagnostics play an essential role in cancer treatment. As per the data published by the World Health Organization (WHO) in September 2021, nearly 70% of deaths from cancer were reported from the low- and mid-income countries across the region. Therefore, rising incidences of cancer is expected to surge the demand of metabolomics services, thereby driving the market growth.

Key Market Segments

The APAC metabolomics services market has been segmented based on service type, application, and country. On the basis of service type, the APAC metabolomics services market is segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on application, the market is segmented into pharmaceutical and biotechnology industry, agritech, and environment. The pharmaceutical and biotechnology industry segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Likewise, the pharmaceutical and biotechnology industry segmented is categorized into biomarker discovery, drug discovery, toxicological testing, and others.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on metabolomics services market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE, BGI, biocrates life sciences ag, C-CAMP, Chenomx Inc., Creative Proteomics, Fred Hutchinson Cancer Research Center, and RTI International are among others.

Reasons to buy report

• To understand the APAC metabolomics services market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC metabolomics services market
• Efficiently plan M&A and partnership deals in APAC metabolomics services market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC metabolomics services market
• Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.

APAC Metabolomics Services Market Segmentation

APAC Metabolomics Services Market –By

Service Type

• Targeted Metabolomics Service
• Untargeted Metabolomics Service

APAC Metabolomics Services Market –By Application

• Pharmaceutical and Biotechnology Industry
  • Biomarker Discovery
  • Drug Discovery
  • Toxicological Testing
  • Others
• Agritech
• Environment

APAC Metabolomics Services Market -By Country

• Japan
• China
• India
• Australia
• South Korea
• Rest of APAC

APAC Metabolomics Services Market -

Company Profiles

• BASF SE
• BGI
• biocrates life sciences ag
• C-CAMP
• Chenomx Inc.
• Creative Proteomics
• Fred Hutchinson Cancer Research Center
• RTI International